Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
-
Cancer Epidemiol. Biomarkers Prev. · Aug 2014
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer.
High fasting plasma proneurotensin concentration was associated with the development of breast cancer in the Malmö Diet and Cancer Study (MDCS). Here, we aimed at replicating the initial finding in an independent second cohort. ⋯ Measurement of plasma proneurotensin warrants further investigation as a blood-based marker for early breast cancer detection.